Potential immunologic effects of statins in cancer following transplantation

Cancer Immunology, Immunotherapy

Volumn 58, Issue 3, 2009, Pages 461-467

  Fildes, J E ^a   Shaw, S M ^a   Williams, S G ^a   Yonan, N ^a  

^a WYTHENSHAWE HOSPITAL   (United Kingdom)

Author keywords

Cancer; Immunomodulation; Statin; Transplantation

Indexed keywords

CYCLOSPORIN; GELATINASE B; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; MEVALONIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STROMELYSIN; TUMOR NECROSIS FACTOR ALPHA;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CANCER EPIDEMIOLOGY; CANCER GROWTH; CANCER INCIDENCE; CANCER INVASION; CARCINOGENESIS; CD4+ T LYMPHOCYTE; CELL ADHESION; CELL DAMAGE; CELL DEATH; CELL TRANSFORMATION; CHEMOTAXIS; DENDRITIC CELL; DRUG MECHANISM; ENZYME INHIBITION; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOSURVEILLANCE; LYMPHOCYTE PROLIFERATION; MALIGNANT TRANSFORMATION; MITOCHONDRION; NATURAL KILLER CELL; NONHUMAN; ORGAN TRANSPLANTATION; PLEIOTROPY; PRIORITY JOURNAL; TUMOR IMMUNITY;

ANIMALS; CELL ADHESION; CELL PROLIFERATION; CHEMOTAXIS; GRAFT REJECTION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE AGENTS; KILLER CELLS, NATURAL; MEVALONIC ACID; MODELS, BIOLOGICAL; NEOPLASMS; ORGAN TRANSPLANTATION;

EID: 58149279160     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-008-0541-2     Document Type: Article

References (53)

1. J Adami H Gabel B Lindelof K Ekstrom B Rydh B Glimelius A Ekbom HO Adami F Granath 2003 Cancer risk following organ transplantation: a nationwide cohort study in Sweden Br J Cancer 89 1221 1227
2. M Arya H Ahmed N Silhi M Williamson HR Patel 2007 Clinical importance and therapeutic implications of the pivotal CXCL12-CXCR4 (chemokine ligand-receptor) interaction in cancer cell migration Tumour Biol 28 123 131
3. CM Ballantyne EJ Podet WP Patsch Y Harati V Appel AM Gotto Jr JB Young 1989 Effects of cyclosporine therapy on plasma lipoprotein levels Jama 262 53 56
4. S Bonovas K Filioussi N Tsavaris NM Sitaras 2006 Statins and cancer risk: a literature-based meta-analysis and meta-regression analysis of 35 randomized controlled trials J Clin Oncol 24 4808 4817
5. PT Brinkkoetter U Gottmann J Schulte FJ van der Woude C Braun BA Yard 2006 Atorvastatin interferes with activation of human CD4(+) T cells via inhibition of small guanosine triphosphatase (GTPase) activity and caspase-independent apoptosis Clin Exp Immunol 146 524 532
6. AJ Brown 2007 Cholesterol, statins and cancer Clin Exp Pharmacol Physiol 34 135 41
7. P Cafforio F Dammacco A Gernone F Silvestris 2005 Statins activate the mitochondrial pathway of apoptosis in human lymphoblasts and myeloma cells Carcinogenesis 26 883 891
8. SC Campbell K Tanabe JP Alexander M Edinger RR Tubbs EA Klein 1994 Intercellular adhesion molecule-1 expression by bladder cancer cells: functional effects J Urol 151 1385 1390
9. E Cernuda-Morollon AJ Ridley 2006 Rho GTPases and leukocyte adhesion receptor expression and function in endothelial cells Circ Res 98 757 767
10. WH Cole 1985 The increase in immunosuppression and its role in the development of malignant lesions J Surg Oncol 30 139 144
11. G Cox KJ O'Byrne 2001 Matrix metalloproteinases and cancer Anticancer Res 21 4207 4219
12. JL Cutts TJ Scallen J Watson AD Bankhurst 1989 Role of mevalonic acid in the regulation of natural killer cell cytotoxicity J Cell Physiol 139 550 557
13. LM Ebert S Meuter B Moser 2006 Homing and function of human skin gammadelta T cells and NK cells: relevance for tumor surveillance J Immunol 176 4331 4336
14. J Fortuny S de Sanjose N Becker M Maynadie PL Cocco A Staines L Foretova M Vornanen P Brennan A Nieters T Alvaro P Boffetta 2006 Statin use and risk of lymphoid neoplasms: results from the European case-control study EPILYMPH Cancer Epidemiol Biomarkers Prev 15 921 925
15. SR Freeman AL Drake LF Heilig M Graber K McNealy LM Schilling RP Dellavalle 2006 Statins, fibrates, and melanoma risk: a systematic review and meta-analysis J Natl Cancer Inst 98 1538 1546
16. GD Friedman ED Flick N Udaltsova DJ Chan Pharm CP Quesenberry Jr LA Habel 2008 Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361,859 recipients Pharmacoepidemiol Drug Saf 17 27 36
17. JG Geng M Chen KC Chou 2004 P-selectin cell adhesion molecule in inflammation, thrombosis, cancer growth and metastasis Curr Med Chem 11 2153 2160
18. R Ghittoni G Napolitani D Benati C Ulivieri L Patrussi F Laghi Pasini A Lanzavecchia CT Baldari 2006 Simvastatin inhibits the MHC class II pathway of antigen presentation by impairing Ras superfamily GTPases Eur J Immunol 36 2885 2893
19. R Ghittoni L Patrussi K Pirozzi M Pellegrini PE Lazzerini PL Capecchi FL Pasini CT Baldari 2005 Simvastatin inhibits T-cell activation by selectively impairing the function of Ras superfamily GTPases Faseb J 19 605 607
20. DS Goodman J Avigan D Steinberg 1963 Studies of cholesterol biosynthesis. V. The time course and pathway of the later stages of cholesterol biosynthesis in the livers of intact rats J Biol Chem 238 1287 1293
21. JZ Guan H Murakami K Yamato J Tanabe J Matsui N Tamasawa T Suda 2004 Effects of fluvastatin in type 2 diabetic patients with hyperlipidemia: reduction in cholesterol oxidation products and VCAM-1 J Atheroscler Thromb 11 56 61
22. WW Hancock B Lu W Gao V Csizmadia K Faia JA King ST Smiley M Ling NP Gerard C Gerard 2000 Requirement of the chemokine receptor CXCR3 for acute allograft rejection J Exp Med 192 1515 1520
23. K Hindler CS Cleeland E Rivera CD Collard 2006 The role of statins in cancer therapy Oncologist 11 306 315
24. H Iwata K Matsuo S Hara K Takeuchi T Aoyama N Murashige Y Kanda S Mori R Suzuki S Tachibana M Yamane M Odawara Y Mutou M Kami 2006 Use of hydroxy-methyl-glutaryl coenzyme A reductase inhibitors is associated with risk of lymphoid malignancies Cancer Sci 97 133 138
25. A Kashani CO Phillips JM Foody Y Wang S Mangalmurti DT Ko HM Krumholz 2006 Risks associated with statin therapy: a systematic overview of randomized clinical trials Circulation 114 2788 2797
26. V Khurana HR Bejjanki G Caldito MW Owens 2007 Statins reduce the risk of lung cancer in humans: a large case-control study of US veterans Chest 131 1282 1288
27. V Khurana A Sheth G Caldito JS Barkin 2007 Statins reduce the risk of pancreatic cancer in humans: a case-control study of half a million veterans Pancreas 34 260 265
28. S Kofler C Schlichting S Jankl T Nickel M Weis 2008 Dual mode of HMG-CoA reductase inhibition on dendritic cell invasion Atherosclerosis 197 105 110
29. S Korom WW Hancock AJ Coito JW Kupiec-Weglinski 1998 Blockade of very late antigen-4 integrin binding to fibronectin in allograft recipients. II. Treatment with connecting segment-1 peptides prevents chronic rejection by attenuating arteriosclerotic development and suppressing intragraft T cell and macrophage activation Transplantation 65 854 859
30. M Landsberger B Wolff F Jantzen C Rosenstengel D Vogelgesang A Staudt JB Dahm SB Felix 2007 Cerivastatin reduces cytokine-induced surface expression of ICAM-1 via increased shedding in human endothelial cells Atherosclerosis 190 43 52
31. MM Lopez JE Valenzuela FC Alvarez MR Lopez-Alvarez GS Cecilia PP Paricio 2006 Long-term problems related to immunosuppression Transpl Immunol 17 31 35
32. M Marcelli GR Cunningham SJ Haidacher SJ Padayatty L Sturgis C Kagan L Denner 1998 Caspase-7 is activated during lovastatin-induced apoptosis of the prostate cancer cell line LNCaP Cancer Res 58 76 83
33. L Mendoza T Carrascal M De Luca AM Fuentes C Salado J Blanco F Vidal-Vanaclocha 2001 Hydrogen peroxide mediates vascular cell adhesion molecule-1 expression from interleukin-18-activated hepatic sinusoidal endothelium: implications for circulating cancer cell arrest in the murine liver Hepatology 34 298 310
34. E Menu E De Leenheer H De Raeve L Coulton T Imanishi K Miyashita E Van Valckenborgh I Van Riet B Van Camp R Horuk P Croucher K Vanderkerken 2006 Role of CCR1 and CCR5 in homing and growth of multiple myeloma and in the development of osteolytic lesions: a study in the 5TMM model Clin Exp Metastasis 23 291 300
35. AA Nabatov G Pollakis T Linnemann WA Paxton MP de Baar 2007 Statins disrupt CCR5 and RANTES expression levels in CD4+ T lymphocytes in vitro and preferentially decrease infection of R5 versus X4 HIV-1 PLoS ONE 2 e470
36. P Nachtigal G Jamborova N Pospisilova K Pospechova D Solichova P Zdansky V Semecky 2006 Atorvastatin has distinct effects on endothelial markers in different mouse models of atherosclerosis J Pharm Pharm Sci 9 222 230
37. CE Nesbit JM Tersak EV Prochownik 1999 MYC oncogenes and human neoplastic disease Oncogene 18 3004 3016
38. S Niwa T Totsuka S Hayashi 1996 Inhibitory effect of fluvastatin, an HMG-CoA reductase inhibitor, on the expression of adhesion molecules on human monocyte cell line Int J Immunopharmacol 18 669 675
39. KT Samson K Minoguchi A Tanaka N Oda T Yokoe S Okada Y Yamamoto Y Watanabe M Yamamoto S Ohta M Adachi 2005 Effect of fluvastatin on apoptosis in human CD4+ T cells Cell Immunol 235 136 144
40. CM Shachaf OD Perez S Youssef AC Fan S Elchuri MJ Goldstein AE Shirer O Sharpe J Chen DJ Mitchell M Chang GP Nolan L Steinman DW Felsher 2007 Inhibition of HMGcoA reductase by atorvastatin prevents and reverses MYC-induced lymphomagenesis Blood 110 2674 2684
41. CR Sirtori 1990 Pharmacology and mechanism of action of the new HMG-CoA reductase inhibitors Pharmacol Res 22 555 563
42. HK Takahashi S Mori H Iwagaki T Yoshino N Tanaka G Weitz-Schmidt M Nishibori 2005 Differential effect of LFA703, pravastatin, and fluvastatin on production of IL-18 and expression of ICAM-1 and CD40 in human monocytes J Leukoc Biol 77 400 407
43. HK Takahashi G Weitz-Schmidt H Iwagaki T Yoshino N Tanaka M Nishibori 2006 Hypothesis: the antitumor activities of statins may be mediated by IL-18 J Leukoc Biol 80 215 216
44. T Tanaka CM Porter JA Horvath-Arcidiacono ET Bloom 2007 Lipophilic statins suppress cytotoxicity by freshly isolated natural killer cells through modulation of granule exocytosis Int Immunol 19 163 173
45. LM Vaessen PP van Miert T van Gelder JN Ijzermans W Weimar 2001 Reassuring effect of pravastatin on natural killer cell activity in stable renal transplant patients Transplantation 71 1175 1179
46. NR Veillard V Braunersreuther C Arnaud F Burger G Pelli S Steffens F Mach 2006 Simvastatin modulates chemokine and chemokine receptor expression by geranylgeranyl isoprenoid pathway in human endothelial cells and macrophages Atherosclerosis 188 51 58
47. M Weis C Heeschen AJ Glassford JP Cooke 2002 Statins have biphasic effects on angiogenesis Circulation 105 739 745
48. G Weitz-Schmidt K Welzenbach J Dawson J Kallen 2004 Improved lymphocyte function-associated antigen-1 (LFA-1) inhibition by statin derivatives: molecular basis determined by X-ray analysis and monitoring of LFA-1 conformational changes in vitro and ex vivo J Biol Chem 279 46764 46771
49. J Wejde M Carlberg M Hjertman O Larsson 1993 Isoprenoid regulation of cell growth: identification of mevalonate-labelled compounds inducing DNA synthesis in human breast cancer cells depleted of serum and mevalonate J Cell Physiol 155 539 548
50. J Wejde M Hjertman M Carlberg B Egestad WJ Griffiths J Sjovall O Larsson 1998 Dolichol-like lipids with stimulatory effect on DNA synthesis: substrates for protein dolichylation? J Cell Biochem 71 502 514
51. JR Xie LN Yu 2007 Cardioprotective effects of cyclosporine A in an in vivo model of myocardial ischemia and reperfusion Acta Anaesthesiol Scand 51 909 913
52. B Yang S Jain SY Ashra PN Furness ML Nicholson 2006 Apoptosis and caspase-3 in long-term renal ischemia/reperfusion injury in rats and divergent effects of immunosuppressants Transplantation 81 1442 1450
53. JJ Yun D Whiting MP Fischbein A Banerji Y Irie D Stein MC Fishbein AE Proudfoot H Laks JA Berliner A Ardehali 2004 Combined blockade of the chemokine receptors CCR1 and CCR5 attenuates chronic rejection Circulation 109 932 937